Delivery Order SPE2DX22D0010-SPE2D825FJS58
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Levorphanol Tablets 2mg, valued at $3,879.10 under a firm fixed-price contract. This is a non-set-aside award issued to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Levorphanol 2 mg tablets (100-count) with a firm fixed price ceiling value of $1,402.57. The contract is non-competitive and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. Performance is located at AmerisourceBergen's Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,854.05 to AmerisourceBergen Drug Corp for the supply of Levorphanol 2 mg tablets in quantities of 100 units. This firm fixed-price contract was awarded on September 16, 2025, with an ultimate completion date of September 17, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside competitive award, reflecting AmerisourceBergen's capability...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,606.83 to AmerisourceBergen Drug Corp for the supply of Levorphanol 2 mg tablets in quantities of 100 units. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by July 11, 2025. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $3,071.22 delivery order to AmerisourceBergen Drug Corp for the supply of Levorphanol 2 mg tablets (100 count) under a firm fixed-price contract. The delivery order, issued on June 18, 2025, with an ultimate completion date of June 20, 2025, was competitively awarded with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $3,071.22 fixed-price delivery order is for the supply of 100 tablets of the medication Levorphanol 2 mg. The contract has an ultimate completion date of May 30, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency Troop Support Medical awarded a $5,554.37 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561399691 Levorphanol tabs 2mg. The prime contractor, Amerisourcebergen Drug Corporation, will deliver the requested pharmaceutical products from its facility located in Conshohocken, Pennsylvania. The delivery order was awarded on July 3, 2023 under an existing indefinite-delivery/indefinite-quantity contract vehicle and has a period of performance...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Levorphanol Tablets 2mg to the U.S. government. The contract, valued at $1,796.80, is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense. The contract has a firm fixed price and a completion date of June 20, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distribution company that holds a...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a Delivery Order (DO) valued at $2,625.38. The contract is for the supply of LEVORPHANOL TABS 2MG and has an ultimate completion date of February 20, 2025. The contracting agency is the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency under the Department of Defense. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award, identified as SPE2DB20D1109 and SPE2DB25FN97A, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4,568,073,816 tablets of the pharmaceutical drug Levorphanol 2 mg, with a ceiling value of $3,969.02 and a performance period through April 30, 2025. The contract is a delivery order without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FJS58Delivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Levorphanol Tablets 2mg with a ceiling value of $10,969.48 and a completion date of September 30, 2025. This competitive award carries no set-aside designation and is being performed at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical prime vendor agreement valued through December 2026 that enables the contractor to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving critical federal medical procurement needs, particularly for military and veteran healthcare systems. The company has demonstrated significant capability in fulfilling federal pharmaceutical requirements through multiple competitive contract awards with the Defense Logistics Agency, consistently delivering diverse therapeutic products including specialty medications, brand-name and generic drugs, and medical devices. This award of Levorphanol tablets reflects the contractor's ongoing role as a vital supplier supporting the Defense Health Agency and broader military healthcare operations through both direct orders and the comprehensive global pharmaceutical support framework established under the prime vendor program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.0k | 9/29/25 |